Arbutus Biopharma Corporation (ABUS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Arbutus Biopharma Corpora...

    NASDAQ: ABUS · Real-Time Price · USD
    4.90
    0.28 (6.06%)
    At close: Sep 11, 2025, 3:59 PM
    4.96
    1.13%
    After-hours: Sep 11, 2025, 07:50 PM EDT

    Arbutus Biopharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 36.33M 26.29M 30.78M 109.28M
    Short-Term Investments
    		 86.29M 99.72M 116.14M 46.03M
    Long-Term Investments
    		 n/a 6.28M 37.36M 35.69M
    Other Long-Term Assets
    		 34K n/a 103K 61K
    Receivables
    		 2.41M 1.78M 1.35M 899K
    Inventory
    		 n/a n/a -2.87M -4.45M
    Other Current Assets
    		 2.28M 4.25M 2.87M 4.45M
    Total Current Assets
    		 127.32M 132.03M 151.14M 160.66M
    Property-Plant & Equipment
    		 4.36M 6.09M 6.81M 8.07M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 4.39M 12.37M 44.28M 43.82M
    Total Assets
    		 131.71M 144.4M 195.42M 204.49M
    Account Payables
    		 2.32M 3.22M 3.52M 3.17M
    Deferred Revenue
    		 7.57M 11.79M 16.46M 7.64M
    Short-Term Debt
    		 483K n/a 372K 383K
    Other Current Liabilities
    		 1.85M 3.7M 16.81M -383K
    Total Current Liabilities
    		 15.62M 22.49M 32.86M 11.22M
    Long-Term Debt
    		 n/a 6.95M n/a n/a
    Other Long-Term Liabilities
    		 15.05M 7.6M 17.9M 21.59M
    Total Long-Term Liabilities
    		 18.72M 15.9M 25.71M 23.82M
    Total Liabilities
    		 34.34M 38.38M 58.57M 35.05M
    Total Debt
    		 1.29M 8.72M 2.19M 2.61M
    Common Stock
    		 1.41B 1.35B 1.32B 1.29B
    Retained Earnings
    		 -1.35B -1.28B -1.2B -1.13B
    Comprehensive Income
    		 -48.13M -48.42M -50.49M -48.34M
    Shareholders Equity
    		 97.37M 106.02M 136.85M 169.44M
    Total Investments
    		 86.29M 106M 153.5M 81.72M

    Add to Watchlist